Star Imaging and Path Lab Ltd. (STARIMAGIN) Share Price Rises 9.18% Today
- August 12, 2026
- Posted by: Harsh Piplani
- Category: News
Star Imaging and Path Lab Ltd. at Rs 98 rose 9.18% today, taking its market capitalisation to Rs 142.15 crore in a Micro Cap move tracked on BSE.
Star Imaging and Path Lab Ltd. Share Price moved to Rs 98 on 12 August 2026, up 9.18% from the previous close of Rs 89.76, lifting the company’s market capitalisation to Rs 142.15 crore. For investors scanning Stock Market Today and Top Gainers Today lists, this was a notable price rise in a Micro Cap counter, especially because the stock opened at Rs 98, traded between Rs 98 and Rs 98.73, and was already holding a firm premium to the previous close early in the session.
The supplied data confirms the move in price and trading activity, though it does not establish a company-specific catalyst behind today’s rise. Even so, the event matters because Star Imaging and Path Lab Ltd. Share Price crossed the qualifying bar for its Micro Cap category and entered the day’s market conversation as a top gainer. On BSE, total volume stood at 7,000 shares and turnover came in at Rs 0.07 crore, which frames the move as meaningful in percentage terms while still being a relatively small absolute traded value.
For readers looking for Star Imaging and Path Lab Ltd. Share Price Today, Star Imaging and Path Lab Ltd. Stock News, or a focused stock analysis, the useful questions are straightforward: what exactly happened in today’s trading, what do the available financial metrics say, how does valuation compare with the Healthcare industry benchmark, and why is this stock getting attention on Univest and across today’s Market News flow. This Univest review addresses each of those questions using only verified supplied data.
Star Imaging and Path Lab Ltd. (STARIMAGIN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 98 |
| Previous Close | Rs 89.76 |
| Today's Change | +Rs 8.24 (+9.18%) |
| Day Open | Rs 98 |
| Day High | Rs 98.73 |
| Day Low | Rs 98 |
| Current Volume (BSE) | 7,000 |
| BSE Traded Volume | 7,000 |
| Combined NSE + BSE Volume | 7,000 |
| Turnover | Rs 0.07 crore |
| Market Capitalisation | Rs 142.15 crore |
| Market Cap Category | Micro Cap |
Star Imaging and Path Lab Ltd. (STARIMAGIN) traded at Rs 98. versus the previous close of Rs 89.76, a rise of 9.18%. The stock opened at Rs 98, reached Rs 98.73, touched Rs 98. Reported volume was 7,000.
Star Imaging and Path Lab Ltd. (STARIMAGIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 142.15 crore |
| P/E Ratio | 8.11x |
| P/B Ratio | 1.35x |
| ROE | 34.28% |
| ROCE | 23.64% |
| EPS | Rs 11.07 |
| Dividend Yield | 0% |
Star Imaging and Path Lab Ltd. was valued at a P/E ratio of 8.11x, a P/B ratio of 1.35x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 34.28% and ROCE of 23.64%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 11.07, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Star Imaging and Path Lab Ltd. Fundamental Analysis shows a small-capitalisation healthcare services company with a market cap of Rs 142.15 crore and a P/E ratio of 8.11. On valuation alone, that multiple is materially below the industry median and average supplied in the sector benchmark, which is one reason the stock can attract attention during a price rise. The P/B ratio is 1.35, adding another lens to valuation relative to the accounting net worth attached to the business.
Profitability metrics are also notable. Return on equity stands at 34.28%, while return on capital employed is 23.64%. ROE at 34.28% indicates the company has generated a strong return relative to shareholder equity based on the supplied figures, and ROCE at 23.64% shows healthy returns on capital employed. These are important data points because investors frequently use them to judge whether a lower P/E reflects weak quality or whether the company is still delivering solid operating efficiency. In this case, the supplied numbers point to strong return ratios rather than weak profitability.
EPS is Rs 11.07, which represents the earnings attributable to each share. With Star Imaging and Path Lab Ltd. Share Price at Rs 98, that EPS aligns arithmetically with the stated P/E of 8.11 and supports the valuation narrative supplied in the dataset. The dividend yield is 0, which means the current or historical payout reflected in the data is not contributing to the stock’s return profile at this price. That does not make the company weaker or stronger by itself, but it does mean the market’s focus is more likely to remain on earnings, valuation and return ratios than on income distribution.
The key takeaway from this fundamental analysis is that Star Imaging and Path Lab Ltd. Share Price is being discussed after a significant one-day gain, but the stock is not trading at a high earnings multiple relative to the industry data provided. When Univest compares that with the company’s ROE of 34.28% and ROCE of 23.64%, the figures provide at least some financial context for investor attention. To understand that context better, it helps to compare the stock directly with its Healthcare industry benchmark.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 8.11x |
| Benchmark Median P/E | 31.73x |
| Benchmark Average P/E | 117.22x |
| Benchmark P/E Range | 8.11x to 1,660.93x |
| Company P/B Ratio | 1.35x |
| Benchmark Median P/B | 2.01x |
| Company ROE | 34.28% |
| Benchmark Median ROE | 14.66% |
| Company ROCE | 23.64% |
| Benchmark Median ROCE | 18.85% |
| Company Market Capitalisation | Rs 142.15 crore |
| Benchmark Median Market Cap | Rs 102.78 crore |
Star Imaging and Path Lab Ltd. (STARIMAGIN) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Star Imaging and Path Lab Ltd. (STARIMAGIN) has a P/E ratio of 8.11x, which is below the benchmark median of 31.73x, a difference of -74.44%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Star Imaging and Path Lab Ltd. (STARIMAGIN) has a ROE of 34.28%, which is above the benchmark median of 14.66%, a difference of +133.83%. Star Imaging and Path Lab Ltd. (STARIMAGIN) has a ROCE of 23.64%, which is above the benchmark median of 18.85%, a difference of +25.41%.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
Star Imaging and Path Lab Ltd. operates in Healthcare, specifically within Hospital & Healthcare Services, and the supplied sector benchmark covers the same industry with 40 companies. That matters because it allows a like-for-like comparison rather than a broad market comparison. On this basis, the company’s P/E of 8.11 sits well below the benchmark median of 31.73 and far below the benchmark average of 117.22. In fact, the company’s P/E also matches the benchmark minimum of 8.11, while the benchmark maximum stretches to 1660.93 across 33 companies with P/E data.
The valuation gap extends to price-to-book as well. Star Imaging and Path Lab Ltd. has a P/B of 1.35 versus a benchmark median of 2.01 and average of 2.65 across 40 companies. The benchmark range runs from -9.58 to 11.81, which highlights how widely market pricing varies within this industry. On profitability, the comparison is more balanced. The company’s ROE of 34.28% is well above the industry median of 14.66 but slightly below the industry average of 36.33. Its ROCE of 23.64% is above both the industry median of 18.85 and the industry average of 21.42.
Market capitalisation also gives perspective. At Rs 142.15 crore, the company is above the benchmark median market cap of Rs 102.78 crore but far below the benchmark average of Rs 450.35 crore, with the industry range running from Rs 4.86 crore to Rs 2,561.88 crore. That places the company in the lower end of the size spectrum even though it is not among the smallest names in the same industry sample.
For investors following Star Imaging and Path Lab Ltd. Stock News, this benchmark picture is significant: today’s price rise occurred in a company that screens as lower valued than the industry on both P/E and P/B, while posting ROE and ROCE figures that compare favourably with the benchmark median. Univest sees that combination as one of the more useful data-backed reasons to keep the stock on watch, even though the supplied data does not identify a specific trigger for today’s move.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,561.88 | 33.61 | 6.93 | -2.6 | 16.92 |
| KMC Speciality Hospitals (India) Ltd. | KMCSHIL | 1,979.85 | 42.36 | 9.41 | 22.42 | 25.85 |
| Krsnaa Diagnostics Ltd. | KRSNAA | 1,839.92 | 18.4 | 1.9 | 0 | 129.09 |
| Shalby Ltd. | SHALBY | 1,749.22 | 46.71 | 1.74 | 5.19 | 6.85 |
| SURAKSHA DIAGNOSTIC LIMITED | SURAKSHA | 1,383.53 | 41.75 | 5.49 | 13.93 | 22.94 |
Star Imaging and Path Lab Ltd. (STARIMAGIN) has a P/E ratio of 8.11x compared with the displayed peer median of 41.75x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 34.28% compares with a peer median of 5.19% across the companies shown in the table. ROCE stood at 23.64% versus the displayed peer median of 22.94%, providing a capital-efficiency comparison. Star Imaging and Path Lab Ltd. (STARIMAGIN) has a market capitalisation of Rs 142.15 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Star Imaging and Path Lab Ltd. can also be understood by placing it beside listed Hospital & Healthcare Services peers in the supplied set. Compared with Dr Agarwals Eye Hospital Ltd., which has a market cap of Rs 2,561.88 crore, P/E of 33.61, P/B of 6.93, ROE of -2.6% and ROCE of 16.92%, Star Imaging and Path Lab Ltd. is much smaller but trades at a far lower earnings and book multiple while showing higher ROE and ROCE. Against KMC Speciality Hospitals (India) Ltd., the subject company again trades at a lower P/E of 8.11 versus 42.36 and lower P/B of 1.35 versus 9.41, while its ROE of 34.28% exceeds KMC’s 22.42%, though its ROCE of 23.64% is slightly below KMC’s 25.85%.
Versus Krsnaa Diagnostics Ltd., which has a market cap of Rs 1,839.92 crore, P/E of 18.4, P/B of 1.9, ROE of 0% and ROCE of 129.09%, the picture is mixed. Star Imaging and Path Lab Ltd. is cheaper on P/E and P/B and stronger on ROE, but Krsnaa’s ROCE is dramatically higher. Compared with Shalby Ltd., the company again appears lower valued, with Shalby trading at a P/E of 46.71 and P/B of 1.74 against Star Imaging and Path Lab Ltd.’s 8.11 and 1.35 respectively, while Star Imaging and Path Lab Ltd. also shows stronger ROE and ROCE than Shalby’s 5.19% and 6.85%.
Another relevant comparison is GPT Healthcare Ltd., where the peer P/E is 27.91, P/B is 4.68, ROE is 33.06% and ROCE is 25.56%. Here, Star Imaging and Path Lab Ltd. still looks cheaper on valuation, has a marginally higher ROE, but a slightly lower ROCE. The overall peer picture suggests that Star Imaging and Path Lab Ltd. Share Price is being discussed after today’s rise from a base of relatively modest valuation multiples compared with several larger healthcare services peers, even though its market cap remains much smaller than all names in the peer set supplied by Univest.
Why Investors Are Watching Star Imaging and Path Lab Ltd.
Investors are watching this stock because today’s move combined a meaningful single-day share price gain with valuation and profitability data that stand out within the same industry sample. Star Imaging and Path Lab Ltd. Share Price has entered the conversation not only as a Micro Cap top gainer on BSE, but also as a healthcare services company trading at lower-than-benchmark multiples while posting robust return ratios.
- Verified price action: the stock rose 9.18% to Rs 98 from Rs 89.76, with a day high of Rs 98.73 and turnover of Rs 0.07 crore.
- Market-cap context: the company is classified as a Micro Cap with a market capitalisation of Rs 142.15 crore.
- Valuation context: P/E is 8.11 and P/B is 1.35, both below supplied industry median figures.
- Profitability context: ROE stands at 34.28% and ROCE at 23.64%, both above the industry median.
- Peer positioning: the company trades at lower multiples than several listed healthcare services peers.
What investors may monitor next is whether Star Imaging and Path Lab Ltd. Share Price continues to hold near today’s upper band, and whether subsequent market activity adds depth to this move. On Univest, readers can track how the stock behaves relative to its current valuation, peer set and broader Healthcare industry benchmark without treating today’s rise as a conclusion by itself.
About Star Imaging and Path Lab Ltd.
Star Imaging and Path Lab Ltd. is positioned within the Healthcare sector and specifically within the Hospital & Healthcare Services industry. Based on the supplied classification, the company operates in a segment of the Indian Stock Market that includes diagnostics, hospitals and related healthcare service providers. That places it in a business environment where investors often compare companies on valuation multiples such as P/E and P/B, as well as on profitability metrics like ROE and ROCE.
The company’s market capitalisation of Rs 142.15 crore makes it a Micro Cap name within this industry context. By size, it is well below large listed peers such as Dr Agarwals Eye Hospital Ltd., KMC Speciality Hospitals (India) Ltd., Krsnaa Diagnostics Ltd. and Shalby Ltd., but it still sits above the supplied industry median market cap of Rs 102.78 crore. That makes it a smaller but not negligible listed participant in the same healthcare services universe.
Because the available company data here is classification-led rather than description-led, the most grounded way to understand Star Imaging and Path Lab Ltd. is through its industry positioning. It belongs to a healthcare services basket where market pricing ranges widely, profitability differs sharply across companies, and investors regularly compare operational efficiency with valuation. In that context, today’s Star Imaging and Path Lab Ltd. Share Price move has drawn attention because the stock combines small size with a low earnings multiple and strong return ratios relative to key benchmark medians.
Track Star Imaging and Path Lab Ltd. Share Price on Univest
Use Star Imaging and Path Lab Ltd. (STARIMAGIN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Readers who want to follow Star Imaging and Path Lab Ltd. Share Price more closely can track the stock on Univest for live share price moves, market cap updates, valuation ratios, profitability metrics and broader market insights. Univest also helps users watch how Star Imaging and Path Lab Ltd. Share Price Today compares with sector benchmarks, peer multiples and intraday price action on BSE.
For investors researching Star Imaging and Path Lab Ltd. Stock News, Univest provides a structured way to monitor share price live movements, 52-week levels when available, financial ratios, shareholding pattern updates when disclosed, and market-wide context across Stocks in News and Market Movers lists. That makes Univest a practical information layer for following this stock’s price rise without converting market activity into an investment recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Star Imaging and Path Lab Ltd. Share Price rise today?
Ans. The supplied data confirms Star Imaging and Path Lab Ltd. Share Price rose 9.18% to Rs 98 from Rs 89.76 today. It qualifies as a price rise event in the Micro Cap category, though no company-specific catalyst is established in.
What is Star Imaging and Path Lab Ltd. Share Price Today?
Ans. Star Imaging and Path Lab Ltd. Share Price Today is Rs 98. The stock opened at Rs 98, touched a high of Rs 98.73, stayed at a low of Rs 98, and recorded a day gain of Rs 8.24.
Is Star Imaging and Path Lab Ltd. a top gainer today?
Ans. The stock is part of a tracked price rise event and stands out as a top gainer in percentage terms today. Its 9.18% move is notable for a Micro Cap stock with market capitalisation of Rs 142.15 crore.
What was the trading volume in Star Imaging and Path Lab Ltd. today?
Ans. The supplied data shows total volume of 7,000 shares, all reported on BSE. Turnover was Rs 0.07 crore, which indicates the stock saw a meaningful percentage move on relatively modest absolute traded value.
What is the market capitalisation of Star Imaging and Path Lab Ltd.?
Ans. Star Imaging and Path Lab Ltd. has a market capitalisation of Rs 142.15 crore. That places it in the Micro Cap category, which is important because today’s 9.18% rise is assessed within that market-cap framework.
Is Star Imaging and Path Lab Ltd. expensive on valuation?
Ans. Based on supplied benchmark data, the stock does not appear highly valued on earnings. Its P/E is 8.11 versus the same-industry median of 31.73 and average of 117.22, while its P/B is 1.35 versus a median of 2.01.
How profitable is Star Imaging and Path Lab Ltd.?
Ans. The company’s ROE is 34.28% and ROCE is 23.64%, both strong figures against the industry median levels of 14.66% and 18.85%. EPS stands at Rs 11.07, supporting the supplied earnings-based valuation metrics.
Does Star Imaging and Path Lab Ltd. pay a dividend?
Ans. The supplied dividend yield for Star Imaging and Path Lab Ltd. is 0. That means the current dataset does not reflect a yield contribution, so investor focus today is more on price action, valuation and return ratios.
How does Star Imaging and Path Lab Ltd. compare with healthcare peers?
Ans. The stock trades at a lower P/E than peers such as Dr Agarwals Eye Hospital, KMC Speciality Hospitals, Krsnaa Diagnostics and Shalby. Its ROE of 34.28% is also stronger than several peers in the supplied comparison set.
What does Star Imaging and Path Lab Ltd. do?
Ans. Star Imaging and Path Lab Ltd. is classified in Healthcare under Hospital & Healthcare Services. In market terms, it sits within the listed healthcare services space where investors compare diagnostic and hospital-related businesses on valuation and profitability.
